Biglycan and Atherosclerosis: Lessons from High Cardiovascular Risk Conditions
Atherosclerosis (ATH) and ATH-related diseases represent the leading cause of disability and mortality in the Western world.
Recent Guidelines for Hypertension – A Clarion Call for Blood Pressure Control in India
It is estimated that nearly 1.5 billion adults in the world will have hypertension in the decade ahead.
Management of patients with ventricular arrhythmias and prevention of sudden cardiac death – translating guidelines into practice: results of the European Heart Rhythm Association survey
The European Society of Cardiology (ESC) guidelines on the management of ventricular arrhythmias and prevention on SCD published in 2015 considered the new insights of the natural history of diseases predisposing to SCD.
Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure A Systematic Review and Meta-Analysis
Chronic heart failure (CHF) has become a global epidemic in the 21st century with considerable effects on a patient’s quality of life and a tremendous burden to healthcare systems.
Safety profile and efficacy of Ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial
The cardiomyopathy caused by Chagas disease (ChD) is a major cause of morbidity and mortality in Latin America.
